Home Newsletters Muscle Cell News Direct Cardio-Protection of Dapagliflozin against Obesity-Related Cardiomyopathy via NHE1/MAPK Signaling

Direct Cardio-Protection of Dapagliflozin against Obesity-Related Cardiomyopathy via NHE1/MAPK Signaling

By
Justin.choi
-
0
Scientists investigated the protective effect of Dapa against cardiomyopathy caused by high fat diet-induced obesity in vitro and in vivo.
[Acta Pharmacologica Sinica]

Sorry, but the selected Zotpress account can't be found.

Abstract

RELATED ARTICLES

Exit mobile version